Inventor · disambiguated record
Scott M. Whitcup
Also filed as: WHITCUP SCOTT · WHITCUP SCOTT M
38 granted patents·68 pending applications·467 citations·filing 1994–2024
98Inventor score
Top patents by PatentIndex Score
106 records- 0199US8911768B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2014·Granted Dec 16, 2014·88 cites·3 claims
- 0296US9622957B2Dermal fillerALLERGAN INC·Filed 2015·Granted Apr 18, 2017·11 cites·9 claims
- 0396US8821870B2Method for treating atrophic age related macular degenerationROBINSON MICHAEL R·Filed 2008·Granted Sep 2, 2014·38 cites·4 claims
- 0496US8571802B2Method for determining optimum intraocular locations for drug delivery systemsROBINSON MICHAEL R·Filed 2007·Granted Oct 29, 2013·30 cites·5 claims
- 0594US9161970B2Dermal fillerTEZEL AHMET·Filed 2007·Granted Oct 20, 2015·15 cites·20 claims
- 0694US9050336B2Botulinum toxin formulationBLANDA WENDY M·Filed 2012·Granted Jun 9, 2015·34 cites·7 claims
- 0794US8802129B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2013·Granted Aug 12, 2014·7 cites·4 claims
- 0893US9226931B2Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonistsALLERGAN INC·Filed 2014·Granted Jan 5, 2016·14 cites·20 claims
- 0993US9044477B2Botulinum toxin formulationBLANDA WENDY M·Filed 2007·Granted Jun 2, 2015·30 cites·12 claims
- 1093US8758733B2Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonistsALLERGAN INC·Filed 2013·Granted Jun 24, 2014·19 cites·20 claims
- 1192US7977335B2Methods of preventing and reducing the severity of stress-associated conditionsALLERGAN INC·Filed 2008·Granted Jul 12, 2011·14 cites·1 claims
- 1290US9089478B2Peripherally administered viscous formulationsALLERGAN INC·Filed 2014·Granted Jul 28, 2015·10 cites·8 claims
- 1390US8846094B2Peripherally administered viscous formulationsLYONS ROBERT T·Filed 2007·Granted Sep 30, 2014·14 cites·5 claims
- 1489US9216183B2Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonistsALLERGAN INC·Filed 2014·Granted Dec 22, 2015·6 cites·20 claims
- 1589US8969415B2Intraocular drug delivery systemsROBINSON MICHAEL R·Filed 2006·Granted Mar 3, 2015·15 cites·2 claims
- 1689US7705055B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Apr 27, 2010·4 cites·46 claims
- 1788US7872045B2Combination therapy for glaucoma treatmentALLERGAN INC·Filed 2005·Granted Jan 18, 2011·5 cites·2 claims
- 1888US7060723B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Jun 13, 2006·18 cites·47 claims
- 1987US12156873B2Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the sameADS THERAPEUTICS LLC·Filed 2019·Granted Dec 3, 2024·2 cites·7 claims
- 2086US11078262B2High viscosity macromolecular compositions for treating ocular conditionsHUGHES PATRICK M·Filed 2007·Granted Aug 3, 2021·3 cites·14 claims
- 2186US8642067B2Methods and compositions for intraocular administration to treat ocular conditionsTROGDEN JOHN T·Filed 2007·Granted Feb 4, 2014·4 cites·24 claims
- 2286US5597567ABlocking cell adhesion molecules and treating animals with ocular inflammationUS HEALTH·Filed 1994·Granted Jan 28, 1997·69 cites·12 claims
- 2384US8569272B2Methods for treating a posterior segment of an eyeLYONS ROBERT T·Filed 2008·Granted Oct 29, 2013·5 cites·18 claims
- 2482US2023165945A1Dermal fillerALLERGAN INC·Filed 2022·Application pending·0 cites
- 2581US11622982B2Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eyeAKRIVISTA LLC·Filed 2018·Granted Apr 11, 2023·1 cites·22 claims
- 2681US10363214B2Method for treating atrophic age related macular degenerationALLERGAN INC·Filed 2014·Granted Jul 30, 2019·3 cites·14 claims
- 2781US8802128B2Steroid-containing sustained release intraocular implants and related methodsROBINSON MICHAEL R·Filed 2006·Granted Aug 12, 2014·1 cites·2 claims
- 2879US11903986B2Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eyeAKRIVISTA LLC·Filed 2017·Granted Feb 20, 2024·1 cites·15 claims
- 2979US9233071B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2014·Granted Jan 12, 2016·0 cites·8 claims
- 3078US9265775B2Pharmaceutical compositionsALLERGAN INC·Filed 2013·Granted Feb 23, 2016·2 cites·3 claims
- 3177US12220439B2Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eyeAKRIVISTA LLC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 3277US2008241222A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3377US2008172014A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3477US2008241220A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3577US2008241221A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3677US2025161300A1Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the sameADS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3777US2022370573A1Dermal fillerALLERGAN INC·Filed 2021·Application pending·0 cites
- 3877US2008233171A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3977US2008233173A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 4076US9314425B2Ophthalmic compositions and methods for treating ophthalmic conditionsALLERGAN INC·Filed 2015·Granted Apr 19, 2016·1 cites·6 claims
- 4173US9572859B2Compositions and methods for localized therapy of the eyeALLERGAN INC·Filed 2013·Granted Feb 21, 2017·1 cites·2 claims
- 4271US2022175881A1Method of treating conditions of the eye with an anti-vegf darpinALLERGAN INC·Filed 2021·Application pending·0 cites
- 4371US2011152328A1Combination Therapy For GlaucomaWHITCUP SCOTT M·Filed 2009·Application pending·0 cites
- 4470US9101550B2Compositions for enhancing nail growthALLERGAN INC·Filed 2013·Granted Aug 11, 2015·2 cites·7 claims
- 4570US2005244469A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2004·Application pending·0 cites
- 4670US2006233859A1Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2005·Application pending·0 cites
- 4770US2009148527A1Intraocular formulationROBINSON MICHAEL R·Filed 2007·Application pending·0 cites
- 4870US2012329850A1Methods for treating retinopathy with extended therapeutic effectWHITCUP SCOTT M·Filed 2012·Application pending·0 cites
- 4969US2008241219A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 5068US10792345B2Dermal fillerALLERGAN INC·Filed 2017·Granted Oct 6, 2020·0 cites·11 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott M. Whitcup files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →